Position in AMGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$27,059,024
+$348,892 QoQ
Shares Held
76,905
-5.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $457,189,468 across 19 Drug Manufacturers - General names. AMGN ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
629,201 | $153,801,892 | |
| 2 | ABBV |
AbbVie Inc.
|
436,916 | $95,024,860 | |
| 3 | LLY |
ELI LILLY & Co
|
91,946 | $84,569,172 | |
| 4 | MRK |
Merck & Co., Inc.
|
305,398 | $36,736,325 | |
| 5 | AMGN |
Amgen Inc
This page
|
76,905 | $27,059,024 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
244,135 | $14,806,787 | |
| 7 | PFE |
Pfizer Inc
|
472,519 | $13,268,333 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
75,160 | $10,475,049 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,059,024 | 76,905 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $26,710,132 | 81,605 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,010,189 | 77,995 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,079,796 | 75,498 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $23,043,172 | 73,963 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $19,589,441 | 75,159 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $27,427,159 | 85,122 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,981,009 | 73,551 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $20,413,038 | 71,796 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,322,403 | 70,559 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $18,136,462 | 67,482 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,430,011 | 55,986 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,572,812 | 56,144 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,402,389 | 54,837 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $12,703,093 | 56,358 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $13,548,160 | 55,685 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $13,665,006 | 56,509 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $11,327,239 | 50,350 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $10,819,632 | 50,880 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,622,562 | 59,990 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $17,413,714 | 69,988 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,876,743 | 64,704 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $16,299,026 | 64,129 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $13,867,860 | 58,797 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,704,550 | 38,004 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||